Drugs and Clinic Practice

Remimazolam versus Propofol for children undergoing painless gastroscopy

  • Xue BAI ,
  • Hao LUO ,
  • Yayin HUANG ,
  • Junxiang HUANG ,
  • Yonghong TAN ,
  • Xingrong SONG ,
  • Bilian. LI
Expand
  • Department of Anesthesiology,Guangzhou Women and Children′s Medical Center,Guangzhou 510120,China

Received date: 2023-06-25

  Online published: 2023-11-22

Abstract

Objective To compare the efficacy and safety of remimazolam vs propofol for children undergoing painless gastroscopy. Methods A total of 129 children aged 4 ~ 9 years, ASAⅠ-Ⅱ, BMI 18 - 30 kg/m2, scheduled for painless gastroscopy under intravenous general anesthesia were divided into two groups by random number table method: remimazolam group (R group) and propofol group (P group). Anesthesia was induced with sufentanil 0.2 μg/kg and penehyclidine hydrochloride 0.01 mg/kg. The patients in R group was given 0.5 mg/kg remimazolam and in P group was given 0.3 mg/kg propofol. The success rate of completing painless gastroscopy, heart rate, blood pressure, pulse oxygen saturation, sedation score, narcotrend index were recorded. The onset time, recovery time of orientation and adverse reactions were observed. Results The success rate of sedation in R group and P group was 82.8% and 90.8% respectively,with no statistically difference (P > 0.05). At the time of endoscopic insertion and the end of endoscopic operation, the narcotrend index value of R group was 84.7 ± 10.8, 86.4 ± 4.3, respectively, which was significantly higher than that of P group (58.9 ± 13.2 and 66.2 ± 5.0) (P < 0.05). The postoperative recovery time of R group was (14.2 ± 6.9) min, which was lower than that of P group (23.8 ± 6.7) min(P < 0.05). The incidence of injection pain in R group and P group was respectively 10.9% and 52.3%, with statistically significant difference(P < 0.05). And the other adverse reactions were not statistically significant (P > 0.05). Conclusion Both remimazolam and propofol could be safely and effectively used gastroscopy for children, and remimazolam made patients wake up quickly with a lower incidence of injection pain.

Cite this article

Xue BAI , Hao LUO , Yayin HUANG , Junxiang HUANG , Yonghong TAN , Xingrong SONG , Bilian. LI . Remimazolam versus Propofol for children undergoing painless gastroscopy[J]. The Journal of Practical Medicine, 2023 , 39(19) : 2529 -2533 . DOI: 10.3969/j.issn.1006-5725.2023.19.020

References

1 王思聪,陈芳,林函,等.浙江省218家医院儿科麻醉现状调查[J].浙江医学,2022,44(22):2452-2455,2460.
2 LEE Y M, KANG B, KIM Y B, et al. Procedural Sedation for Pediatric Upper Gastrointestinal Endoscopy in Korea[J]. J Korean Med Sci,2021,36(20):e136.
3 MAHONEY L B, LIGHTDALE J R. The Evolution of Sedation for Pediatric Gastrointestinal Endoscopy[J]. Gastrointest Endosc Clin N Am,2023,33(2):213-234.
4 FATIMA H, IMPERIALE T. Safety Profile of Endoscopist-directed Balanced Propofol Sedation for Procedural Sedation: An Experience at a Hospital-based Endoscopy Unit[J]. J Clin Gastroenterol,2022,56(3):e209-e215.
5 张欢欢,谭永红,宋兴荣,等. 纳布啡预防胃肠镜检查术患儿丙泊酚中长链脂肪乳注射痛的量效关系[J]. 中华麻醉学杂志,2021,41(2):195-197.
6 KEAM S J. Remimazolam: First Approval[J]. Drugs,2020,80(6):625-633.
7 ZHU H, SU Z, HUAI X, et al. Efficacy and safety of remimazolamtosylate for sedation during upper gastrointestinal endoscopy: study protocol for a multicenter randomized controlled trial[J]. Trials,2022,23(1):995.
8 CHEN S, WANG J, XU X, et al. The efficacy and safety of remimazolamtosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial[J]. Am J Transl Res,2020,12(8):4594-4603.
9 杨海扣,孙剑,王巧,等. 瑞马唑仑和右美托咪定镇静在婴幼儿心脏超声检查中的应用比较[J]. 重庆医学,2021,50(23):4062-4064+4070.
10 刘文良,余雪美,熊朝晖. 无痛胃肠镜患者丙泊酚复合舒芬太尼麻醉效果及麻醉复苏情况分析[J]. 河北医学,2023,29(5):872-876.
11 LIU F, CHENG X, WANG Y, et al. Effect of remimazolamtosilate on the incidence of hypoxemia in elderly patients undergoing gastrointestinal endoscopy: A bi-center, prospective, randomized controlled study[J]. Front Pharmacol,2023,14:1131391.
12 何新华,杨艳敏,郭树彬,等. 中国高血压急症诊治规范[J]. 中国急救医学, 2020,40(9):795-803.
13 LARSEN L G, WEGGER M, Lé GREVES S, et al. Emergence agitation in paediatric day case surgery: A randomised, single-blinded study comparing narcotrend and heart rate variability with standard monitoring[J]. Eur J Anaesthesiol,2022,39(3):261-268.
14 SCHüTTLER J, EISENRIED A, LERCH M, et al. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics[J]. Anesthesiology,2020,132(4):636-651.
15 肖兴鹏,郭明,马岚,等. 瑞马唑仑-丙泊酚-舒芬太尼用于无痛胃镜检查术患者麻醉的效果[J]. 中华麻醉学杂志, 2021,41(2):192-194.
16 REX D K, BHANDARI R, DESTA T, et al. A phase Ⅲ study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy[J]. Gastrointest Endosc,2018,88(3):427-437.e6.
17 PASTIS N J, YARMUS L B, SCHIPPERS F, et al. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy[J]. Chest,2019,155(1):137-146.
18 SEPúLVEDA P O, EPULEF V, CAMPOS G. Why do We Use the Concepts of Adult Anesthesia Pharmacology in Developing Brains? Will It Have an Impact on Outcomes? Challenges in Neuromonitoring and Pharmacology in Pediatric Anesthesia[J]. J Clin Med,2021,10(10):2175.
19 HU Q, LIU X, WEN C, et al. Remimazolam: An Updated Review of a New Sedative and Anaesthetic[J]. Drug Des Devel Ther,2022,16:3957-3974.
20 LE J, RAMSEY L B. Enhancing pharmacokinetic and pharmacodynamic knowledge in pediatrics[J]. Pharmacotherapy,2023,43(7):578.
Outlines

/